Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAK2 Blocking Peptide (C-term) | Login | JAK2 Blocking Peptide (C-term) | ||||||||||||||||
|
||||||||||||||||||
| PPARG Blocking Peptide (N-term) | Login | PPARG Blocking Peptide (N-term) | ||||||||||||||||
|
||||||||||||||||||
| MAPK13/14 Blocking Peptide (Center) | Login | MAPK13/14 Blocking Peptide (Center) | ||||||||||||||||
|
||||||||||||||||||
| SPANXA1 Blocking Peptide (N-term) | Login | SPANXA1 Blocking Peptide (N-term) | ||||||||||||||||
|
||||||||||||||||||
| JAK2 Blocking Peptide (C-term) | Login | JAK2 Blocking Peptide (C-term) | ||||||||||||||||
|
||||||||||||||||||
| AFAP1-Y451 Blocking Peptide | Login | AFAP1-Y451 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AFAP1-Y451 Blocking Peptide | Login | AFAP1-Y451 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CDKN1B-Y88 Blocking Peptide | Login | CDKN1B-Y88 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| HUMAN-GAB1(Y259) Blocking Peptide | Login | HUMAN-GAB1(Y259) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| Mouse Fgfr3 Blocking Peptide (Center) | Login | Mouse Fgfr3 Blocking Peptide (Center) | ||||||||||||||||
|
||||||||||||||||||
| MME Blocking Peptide (Center) | Login | MME Blocking Peptide (Center) | ||||||||||||||||
|
||||||||||||||||||
| JAK1 Blocking Peptide (C-term) | Login | JAK1 Blocking Peptide (C-term) | ||||||||||||||||
|
||||||||||||||||||
| Mouse Lyn Blocking Peptide (Center) | Login | Mouse Lyn Blocking Peptide (Center) | ||||||||||||||||
|
||||||||||||||||||
| FGFR4 Blocking Peptide (N-term) | Login | FGFR4 Blocking Peptide (N-term) | ||||||||||||||||
|
||||||||||||||||||
| Phospho-MDM2(S395) Antibody Blocking peptide | Login | Phospho-MDM2(S395) Antibody Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| Phospho-MAP2(Y592) Antibody Blocking peptide | Login | Phospho-MAP2(Y592) Antibody Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| Phospho-IRS2(Y978) Antibody Blocking peptide | Login | Phospho-IRS2(Y978) Antibody Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| Phospho-GAB1(Y259) Antibody Blocking peptide | Login | Phospho-GAB1(Y259) Antibody Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| Phospho-CD34(Y330) Antibody Blocking peptide | Login | Phospho-CD34(Y330) Antibody Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| ANO10 Blocking Peptide (C-Term) | Login | ANO10 Blocking Peptide (C-Term) | ||||||||||||||||
|
||||||||||||||||||
| GNAS Blocking Peptide (N-Term) | Login | GNAS Blocking Peptide (N-Term) | ||||||||||||||||
|
||||||||||||||||||
| FGF12 Blocking Peptide (Center) | Login | FGF12 Blocking Peptide (Center) | ||||||||||||||||
|
||||||||||||||||||
| NCOA2 Blocking Peptide (Center) | Login | NCOA2 Blocking Peptide (Center) | ||||||||||||||||
|
||||||||||||||||||
| APC2 Blocking Peptide (N-Term) | Login | APC2 Blocking Peptide (N-Term) | ||||||||||||||||
|
||||||||||||||||||
| RALGAPA1 Blocking Peptide (N-Term) | Login | RALGAPA1 Blocking Peptide (N-Term) | ||||||||||||||||
|
||||||||||||||||||


